C
Carmen Pilar Simeón-Aznar
Researcher at Autonomous University of Barcelona
Publications - 67
Citations - 1589
Carmen Pilar Simeón-Aznar is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Interstitial lung disease & Medicine. The author has an hindex of 20, co-authored 57 publications receiving 1293 citations. Previous affiliations of Carmen Pilar Simeón-Aznar include Hebron University.
Papers
More filters
Journal Article
Paraneoplastic Vasculitis in Patients with Solid Tumors : Report of 15 Cases
Roser Solans-Laqué,Bosch-Gil Ja,Carmen Pérez-Bocanegra,Albert Selva-O'Callaghan,Carmen Pilar Simeón-Aznar,Miquel Vilardell-Tarrés +5 more
TL;DR: In the authors' patients, resolution of vasculitis following effective treatment of the putatively linked malignancy, and recurrence of Vasculitis heralding tumor recurrence or progression, provide strong evidence for vasculationitis being a true paraneoplastic syndrome.
Journal ArticleDOI
Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients.
Albert Selva-O'Callaghan,Moises Labrador-Horrillo,X. Muñoz‐Gall,Xavier Martínez-Gómez,J Majó-Masferrer,Roser Solans-Laqué,Carmen Pilar Simeón-Aznar,F Morell-Brotard,Miquel Vilardell-Tarrés +8 more
TL;DR: It was concluded that clinical and immunological characteristics allowed the grouping of patients into different types of PM/DM lung-associated disease, and the presence of ASA did not affect survival.
Journal ArticleDOI
Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
Albert Selva-O'Callaghan,Moises Labrador-Horrillo,Roser Solans-Laqué,Carmen Pilar Simeón-Aznar,Xavier Martínez-Gómez,Miquel Vilardell-Tarrés +5 more
TL;DR: No statistically significant differences in mortality, survival, or clinical course were observed between patients positive for MSAs or MAAs and the remaining patients, consistent with those from other published series, although some differences warrant consideration.
Journal ArticleDOI
Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status
Carmen Pilar Simeón-Aznar,Vicent Fonollosa-Pla,Carles Tolosa-Vilella,Gerard Espinosa-Garriga,Manel Ramos-Casals,Mercedes Campillo-Grau,Francisco J. García-Hernández,María Jesús Castillo-Palma,Julio Sánchez-Román,José Luis Callejas-Rubio,Norberto Ortego-Centeno,María Victoria Egurbide-Arberas,Luis Trapiellla-Martínez,María Gallego-Villalobos,Luis Sáez-Comet,José Velilla-Marco,María Teresa Camps-García,Enrique de Ramón-Garrido,Eva María Esteban Marcos,Lucio Pallarés-Ferreres,Carmen Hidalgo-Tenorio,José Mario Sabio-Sánchez,Ricardo Gómez de la Torre,Gonzalo Salvador-Cervello,Juan José Ríos-Blanco,Antonio Gil-Aguado,Miquel Vilardell-Tarrés +26 more
TL;DR: The classification of SSc into dcSSc, lcS sc, and ssSSc subsets is the one that most closely reflects the natural history of the disease, as they presented clear clinical differences and the immunological profile helps to define important visceral alteration as ILD.
Journal ArticleDOI
Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
Roser Solans-Laqué,C. Perez-Bocanegra,A Salud-Salvia,Vicent Fonollosa-Pla,M J Rodrigo,L Armadans,Carmen Pilar Simeón-Aznar,Miquel Vilardell-Tarrés +7 more
TL;DR: It is concluded that there is an increased incidence of antinuclear antibodies in malignant conditions and musculoskeletal symptoms and rheumatic paraneoplastic symptoms and syndromes seem to be more frequent in patients with cancer-related positive ANAs.